DrugAnalyst is voted the leading independent Pharmaceuticals Equity Research provider
We provide global healthcare stock coverage and a database containing 10-years of broker consensus estimates.
Our drug consensus estimates are refreshed on a daily basis, all the numbers here are based on new numbers
published since the release of last quarter’s financial results. The entire database is published once a quarter within our subscription only Global Pharma Workbook.
Full access to our consensus data is free to subscribers of DrugAnalyst Equity Research. For Subscription Enquiries please Contact Us